Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Starting semaglutide therapy is a significant step toward sustainable weight management. Clinical data shows that semaglutide users experience an average 15% body weight reduction over 68 weeks when combined with lifestyle changes. Your first injection sets the foundation for dose escalation, metabolic adaptation, and measurable results.
How Your First Semaglutide Injection Works
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that signals your brain's appetite centers to reduce hunger and increase fullness. When you receive your first injection, the medication enters your subcutaneous tissue and begins circulating within hours. The active compound reaches peak concentrations around 1–3 days post-injection, which is why many patients report early appetite suppression within the first 24–72 hours.
Your initial dose is deliberately low—typically 0.25 mg—to allow your body to adjust and minimize gastrointestinal side effects. This conservative starting point is evidence-based; research demonstrates that gradual dose escalation over 16–20 weeks produces better tolerability and adherence rates than rapid increases. PlexusDx compounds semaglutide at licensed 503A pharmacies to ensure pharmaceutical-grade purity and consistency across every injection.
What to Expect During Your First Week
Most patients experience the onset of appetite suppression between 24 and 48 hours after their initial injection. You may notice reduced interest in foods you typically crave, smaller portion sizes feeling more satisfying, and delayed hunger signals at regular meal times. Some users report a subtle shift in taste preferences, where high-fat or high-sugar foods become less appealing. These changes reflect semaglutide's action on multiple brain regions involved in appetite regulation and food reward.
Mild nausea is the most commonly reported early side effect, affecting 20–30% of new users in the first week. This typically resolves within 3–5 days as your digestive system adapts. Other potential mild effects include slight constipation or loose stools, fatigue, or headache. These symptoms are temporary and rarely severe enough to interrupt treatment. Staying hydrated, eating smaller meals, and avoiding greasy foods can reduce gastrointestinal discomfort.
Timing Your Injections and Dose Escalation Schedule
PlexusDx recommends injecting semaglutide once weekly at the same day and time for consistent circulating levels. You can administer your injection any day of the week—what matters is maintaining a 7-day interval. Most patients choose a convenient day like Sunday or Monday morning. The injection takes less than 30 seconds using a pre-filled pen or syringe, and can be given in the abdomen, thigh, or upper arm.
Your dose remains at $149/month flat, regardless of whether you are taking 0.25 mg or advancing to 2.4 mg over the following months. Your dose may need to go up. Your price won't. Typical escalation follows a 4-week protocol: weeks 1–4 at 0.25 mg, weeks 5–8 at 0.5 mg, weeks 9–12 at 1 mg, weeks 13–16 at 1.7 mg, and maintenance at 2.4 mg. Your PlexusDx provider may adjust this timeline based on your tolerance and response.
When Weight Loss Results Become Noticeable
Most patients begin noticing measurable weight loss between weeks 4 and 8 of treatment. This lag exists because your body is still in the dose-escalation phase, and metabolic adaptation takes time. By week 12, when you reach the 1 mg dose, weight loss acceleration typically becomes evident on the scale and in how your clothes fit. Peak weight loss occurs around week 16–20 when you approach therapeutic doses of 1.7–2.4 mg.
Clinical trials document an average 5–10% body weight reduction by 16 weeks and 15% by 68 weeks in participants maintaining lifestyle changes. Individual results vary based on baseline metabolism, dietary adherence, physical activity, and genetic factors influencing GLP-1 receptor sensitivity. The PlexusDx Precision Peptide Genetic Test ($99 add-on) maps your GLP1R gene variants and 48 other peptide-pathway markers to predict your personalized response trajectory and optimize your treatment plan.
Managing Side Effects and Staying Committed
The most effective strategy for minimizing side effects is eating smaller, protein-rich meals and avoiding high-fat or sugary foods during the first 8–12 weeks. Nausea typically resolves on its own, but ginger tea, vitamin B6, or over-the-counter antiemetics like ondansetron can provide relief if needed. Staying hydrated with at least 64 ounces of water daily supports digestion and reduces headache risk. If side effects persist beyond 2 weeks or become severe, contact your PlexusDx provider immediately.
Commitment during the first month is critical because early dropout rates are highest when patients experience temporary nausea without yet seeing weight loss results. Understanding that weeks 1–4 are an adjustment phase—not a failure—helps many patients push through. By week 8, when appetite suppression is profound and initial weight loss appears, motivation naturally increases. PlexusDx removes financial barriers with flat monthly pricing starting at $149/month, no insurance required, and HSA/FSA eligibility.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I feel the semaglutide injection when I inject it?
No. Semaglutide injections use ultra-fine 31-gauge needles that most patients report feeling minimally or not at all. The injection itself takes 5–10 seconds. Mild pressure or a small pinch is normal, but true pain is rare and usually indicates incorrect needle angle. PlexusDx provides detailed injection training videos and phone support to ensure proper technique.
How much weight will I lose in my first month?
Most patients lose 2–4 pounds in the first month, primarily from reduced calorie intake as appetite suppression kicks in. Significant weight loss (8–15 pounds monthly) typically begins in weeks 5–12 as your dose increases. Your exact timeline depends on your starting weight, metabolism, diet quality, and exercise frequency. The PlexusDx Precision Peptide Genetic Test can identify your GLP1R rs6923761 variant status, which influences receptor sensitivity and predicted weight loss velocity.
What makes PlexusDx semaglutide different from other compounded options?
PlexusDx sources all semaglutide from licensed 503A compounding pharmacies—never 503B facilities—ensuring pharmaceutical-grade quality and sterility. Your flat monthly pricing of $149/mo covers unlimited dose adjustments, with no per-dose markup or hidden escalation fees. PlexusDx also offers the Precision Peptide Genetic Test to map your individual peptide-pathway genetics and optimize your medication selection.
Is nausea with semaglutide permanent or will it go away?
Nausea is almost always temporary, resolving within 3–7 days as your body adapts. Persistent nausea beyond 2 weeks is uncommon and usually signals that smaller meal portions or dietary adjustments are needed. If nausea persists, your PlexusDx provider can recommend anti-nausea medications or adjust your dose timeline. The vast majority of long-term semaglutide users experience zero nausea after the first month.
Does the Precision Peptide Genetic Test tell me if semaglutide will work for me?
The PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides, including your GLP1R and GIPR gene variants, to predict your response pattern and optimal medication choice. While genetic variants influence efficacy, environmental factors like diet and exercise are equally important. The test costs $99 after your first month and provides actionable insights to personalize your treatment trajectory and potentially recommend GLP-Squared (dual semaglutide + tirzepatide) if your genetics suggest synergistic benefit.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can I Take Ozempic on Blood Thinners: A Deep Dive into Safe Weight Loss and Medication Management
Do You Gain Weight Back When You Stop Taking Ozempic? Understanding the Implications of Discontinuation